FDAnews Drug Daily Bulletin

PHARMAXIS OBTAINS LICENSE TO MANUFACTURE INHALATION POWDERS FOR HUMAN USE

April 10, 2006
A A

Friday morning, Pharmaxis Ltd., a specialist pharmaceutical company, revealed that it obtained a Good Manufacturing Practices License from the Therapeutic Goods Administration or TGA to manufacture inhalation powders for human use that excludes microbiological testing.
Trading Markets